Company
Product List
Offer to buy
Offer to sell
Sign In
Join
Help
Languages
English
繁體中文
簡體中文
Changchun Changsheng Life Sciences Ltd.
Home
Company Profile
Products
Video
Inquiry
Contact Us
Recommended Results
Clinical Meningococcal Polysaccharide Vaccine
Category :
Chemicals->Chemical->aspalthic products
View Larger Picture
View Larger Picture
View Larger Picture
Product Specification
Model No:
0.5ml/vial
Country
CN
Minimum Order
5000
Payment Term
L/C,T/T
Product Detail
<p class="MsoNormal">
The vaccine is indicated for active immunization against invasive meningococcal disease caused by epidemic Neisseria meningitidis serogroups A,C,Y,W135.
</p>
<p class="MsoNormal">
<span> [Description]<br />
The vaccine is a preparation of preparation polysaccharide antigens extracted from the culture of Neisseria meningitidis group ACYW135 respectively and Iyophilized after addition of an appropriate stabilizer. The final product looks like a white crisp cake. It shall dissolve in the accompanying Phosphate buffered saline (PBS) immediately, and turn into a clear liquid after reconstitution.<br />
Active constituent: Neisseria meningitidis group ACYW135 capsular polysaccharides.<br />
Subsidiary materials: All the components of subsidiary materials approved shall be listed.<br />
Vaccine diluent: Sterile, pyrogen-free PBS.<br />
[Specifications]<br />
0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose, containing 200μg of meningococcal polysaccharide (50μg of each polysaccharide of group A,C,Y,W135).</span>
</p>
<p class="MsoNormal">
<span>[Administration and dosage]<br />
(1) Reconstitute the vaccine with the accompanying PBS as the stated value. Shake and inject immediately.<br />
(2) The vaccine shall be injected s.c. at deltoid insertion area of the lateral upper arm.<br />
(3) One single human dose of 0.5 ml vaccine is required. The immunization shall be carried out before the epidemic season of epidemic cerebrospinal meningitis.<br />
[Adverse reactions]<br />
Common adverse reactions:<br />
(1) Pain, tenderness, mild or moderate erythema, swelling and infiltration at the injection site within 24 hours after vaccination, which can subside spontaneously within 2-3 days in most cases.<br />
(2) Transient fever may occur after vaccination, most of which are mild, can be relieved spontaneously within 1-2 days, and need no particular treatment. The recipients with moderate fever or the fever lasting for more than 48 hours may<br />
receive symptomatic treatment.<br />
Rare adverse reactions:<br />
(1) Severe fever: Symptomatic treatment shall be given to prevent febrile convulsion.<br />
(2) Serious erythema and, swelling at the injection site or other complications: symptomatic treatment shall be given.<br />
Extremely rare adverse reactions:<br />
(1) Allergic rash: Rash may occur with 72 hours after vaccination. Antianaphylactic treatment should be given to the recipients with rash promptly.<br />
(2) Anaphylactic shock: Anaphylactic shock may occur within one hour after vaccination. Emergency treatment including injection with adrenaline shall be given promptly.<br />
(3) Allergic purpura: Antianaphylactic treatment with corticosteroid should be given to the recipients with allergic purpura. Give anti-allergic treatment with cortical steroids. If the treatment is inappropriate or delayed, purpura nephritis may be complicated.<br />
(4) Angioneurotic edema and allergic neuritis may occur occasionally.<br />
(5) Allergic exfoliative dermatitis cases have been reported occasionally.<br />
<br />
[Feature]<br />
Fill a gap in our country for the first time by developing 4-valent vaccine .<br />
Improve traditional purification technology to eliminate nucleic acid and protein.<br />
Improve WHO specifications and high harvest rate. Develop new type of stabilizer. Improve national quality standards.<br />
<br />
1.Group ACYW135 <br />
2.Group A+C <br />
3.prevent epidemic cerebrospinal meningitis </span>
</p>
<p class="MsoNormal">
<span>4.purified capsular polysaccharide antigens <br />
<img src="http://i.bosscdn.com/product/18/f2/13/d46381b9bd8edf65b150508726.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=9&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="-ACYW135" alt="-ACYW135" /><br />
<br />
</span>
</p>
<p class="MsoNormal">
<br />
</p>ccls-vaccine.com
More Products from this Supplier
Medical Prevent Rabies Vaccine
Clinical Rabies Vaccine For Human Use
Prevent Hepatitis A Virus Vaccine
Trivalent Influenza vaccine (Split Virion)
[ Back Products Catalog ]
Commerce Member:
Please log in your ID and password, we will later fill in relating info.
ID:
Password:
Remember my ID on this computer
Complete this form below to send out your enquiries.
All enquiries will be automatically sent to the company you want to develop.
Subject
Content
(Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)
Company Profile:
*
Company Name
*
E-mail
*
Country
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
Contact Person
URL
*
Phone
-
-
Fax
-
-
*
Postal code
*
City
*
Street Address
*
Business Nature
Distributor
Exporter
Importer
Manufacturer
Whole Sale
Retailer
Reseller
Retrofitter
User
Others, please specify:
*
Security Code
Enter the security code.
Site Map l
Privacy Policy l
Company Profile l
Corporate Proposal l
Contact Us l
Help l
Advertise With Us l
World Trade Link
.